Copley Scientific has introduced a modified induction port fixture on its sample preparation unit (SPU) Model 2000, the company said. The modification allows for the use of a fluticasone propionate/salmeterol xinafoate (FP/SX) induction port in addition to NGI and ACI induction ports.
Copley Scientific Sales Director Mark Copley commented, “Fully automating cascade impactor testing can be challenging, because of its complexity and the need for complex validation and maintenance. We find that many of our customers regard semi-automation as a more practical and cost-effective option. Our latest modification to the SPU 2000 induction port fixture reflects the increasing use of the special FP/SX induction port. This modification enables semi-automated drug recovery from of a wider range of cascade impactor components, making the SPU 2000 an even more cost effective laboratory tool.”
Read the Copley Scientific press release.
